The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.

The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. J Dermatol Sci. 2018 Jun; 90(3):343-356.

View in: PubMed

subject areas

Adolescent
Aged, 80 and over
Antineoplastic Agents
Apoptosis
Cell Cycle
Cell Line, Tumor
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p27
Down-Regulation
Drug Evaluation, Preclinical
Fatty Acids, Unsaturated
Humans
Inhibitory Concentration 50
Lymphoma, T-Cell, Cutaneous
Male
Middle Aged
Naphthalenes
Proteasome Endopeptidase Complex
Retinoid X Receptors
Signal Transduction
S-Phase Kinase-Associated Proteins
Tetrahydronaphthalenes

authors with profiles

W. Timothy Garvey